The aims of this review were (1) to synthesise data from the literature on neuropathic pain prevalence in women after breast cancer treatment; (2) to investigate whether the prevalence of neuropathic pain differed between studies using ...

Book Title: The Prevalence of Neuropathic Pain is High After Treatment for Breast Cancer
Author:
Published on 2017 by
ISBN: /
Total Page:
Book Category:
Book is About: Breast Cancer Treatment
Get The Prevalence of Neuropathic Pain is High After Treatment for Breast Cancer eBook


Get the Ebook

Abstract : Abstract: Pain is common, but often poorly managed after breast cancer treatment. Screening questionnaires and the Neuropathic Pain Special Interest Group (NeuPSIG) criteria are 2 clinical approaches used to determine whether pain has neuropathic components, which may enable better pain management. The aims of this review were (1) to synthesise data from the literature on neuropathic pain prevalence in women after breast cancer treatment; (2) to investigate whether the prevalence of neuropathic pain differed between studies using screening questionnaires and the NeuPSIG criteria. We searched for studies that administered a validated neuropathic pain screening questionnaire and/or the NeuPSIG criteria to women treated for early-stage (I-III) breast cancer. Thirteen studies using screening questionnaires ( N = 3792) and 3 studies using components of the NeuPSIG criteria ( N = 621) were included. Meta-analyses were conducted for questionnaire data but not for NeuPSIG criteria data because of inadequate homogeneity. Among all participants treated for early-stage breast cancer, pooled prevalence estimates (95% confidence interval) ranged between 14.2% (8.3-21.4) and 27.2% (24.7-88.4) for studies using screening questionnaires; studies using NeuPSIG criteria reported prevalence rates from 24.1% to 31.3%. Among those who reported pain after treatment, the pooled prevalence estimate (95% confidence interval) of neuropathic pain from screening questionnaires ranged from 32.6% (24.2-41.6) to 58.2% (24.7-88.4); studies using NeuPSIG criteria reported prevalence rates from 29.5% to 57.1%. These prevalence estimates are higher than those reported for other types of cancer, and emphasise the need to assess the contribution of neuropathic pain after breast cancer treatment. Trial registration: PROSPERO registration CRD42015029987. Abstract : Supplemental Digital Content is Available in the Text.

From the most popular Breast Cancer Treatment Books, The Prevalence of Neuropathic Pain is High After Treatment for Breast Cancer is the one of great book to have. You can get ebook from:

There are so many ebooks about The Prevalence of Neuropathic Pain is High After Treatment for Breast Cancer that are available to have. Thinking of having The Prevalence of Neuropathic Pain is High After Treatment for Breast Cancer ebook? You are in the right place. Get the ebook The Prevalence of Neuropathic Pain is High After Treatment for Breast Cancer by: .

Ebook entitled: The Prevalence of Neuropathic Pain is High After Treatment for Breast Cancer

Get the Ebooks

Book Details:
  1. Book was ranked at 35 by Google Books for The Prevalence of Neuropathic Pain is High After Treatment for Breast Cancer
  2. The Prevalence of Neuropathic Pain is High After Treatment for Breast Cancer published by since 2017 with ISBNs. The book ISBN 13 Code is and ISBN 10 Code is
  3. Reading Mode in Text Status is false and Reading Mode in Image Status is false
  4. The book has " Pages" is Printed at BOOK under Category
  5. Rated by Raters and have average rate at ""
  6. eBook Maturity (Adult Book) status is NOT_MATURE
  7. eBook written in en
  8. Book Preview Address: http://books.google.com/books?id=dkTjvQEACAAJ&dq=Breast+Cancer+Treatment&hl=&cd=314&source=gbs_api

Book Preview


Get Ebooks

The Button is not working? Try The Alternative links for "The Prevalence of Neuropathic Pain is High After Treatment for Breast Cancer by: ":